Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,200 HIV / AIDS
clinical trials

HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Newark, NJ
Click here to add this to my saved trials
HIV INfections Clinical Trial
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
Status: Upcoming, Phase III
Updated: 12/31/1969
mi
from
Stony Brook, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Longview, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Proof of Concept Study of GSK3640254 in Human Immunodeficiency Virus-1 (HIV-1) Infected Treatment-naive Adults
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
HIV INfections Clinical Trial
Long-Acting Cabotegravir Plus VRC01LS for Viral Suppression in Adults Living With HIV-1
Status: Upcoming, Phase II
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
A Mobile Gaming App to Improve ART Adherence for Youth
Status: Upcoming
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
HIV INfections Clinical Trial
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Memphis, TN
Click here to add this to my saved trials
HIV INfections Clinical Trial
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Impact of Physical Activity and Diet on Symptom Experience in People Living With HIV
Status: Upcoming, Phase
Updated: 12/31/1969
mi
from
Seattle, WA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in HIV-1-infected Participants on Suppressive cART
Status: Upcoming, Phase I, II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Effect of Methamphetamine on Residual Latent HIV Disease Study
Status: Upcoming, Phase IV
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Consent for Use of Stored Patient Specimens for Future Testing
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Omaha, NE
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Portland, OR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
San Francisco, CA
Click here to add this to my saved trials
Primary Immune Deficiency Clinical Trial
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Ankara,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
La Jolla, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Ophthalmology, Other, Reproductive Clinical Trial
Natural History Study of SCID Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: The DC Cohort
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
mi
from
Decatur, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
mi
from
Santa Clara, CA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
mi
from
Buffalo, NY
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
mi
from
Miami, FL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
mi
from
Sacramento, CA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New Orleans, LA
Click here to add this to my saved trials
HIV/AIDS Clinical Trial
Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Juan,
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Augusta, GA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Columbia, SC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Bellaire, TX
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Garden Grove, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
San Francisco, CA
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
St. Louis, MO
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Tampa, FL
Click here to add this to my saved trials
HIV-1 Clinical Trial
Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018)
Status: Enrolling, Phase III
Updated: 10/28/2015
mi
from
Torrance, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Miami, FL
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Providence, RI
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Sacramento, CA
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
Washington DC,
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Clinical Trial
Comparison of MK-1439A and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus (HIV)-Infected Participants (MK-1439A-021)
Status: Enrolling, Phase III
Updated: 3/9/2016
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Early Infant HIV Treatment in Botswana
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Gaborone,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
mi
from
San Diego, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
mi
from
Seattle, WA
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Human Immunodeficiency Virus (HIV) Infection Clinical Trial
A Study to Evaluate the Effects of Multiple Doses of MK-1439 (Doravirine) on Pharmacokinetics of Methadone in Participants Requiring Methadone Maintenance Therapy (MK-1439-045)
Status: Enrolling, Phase I
Updated: 3/30/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), For Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women Who Have Sex With Men
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Bronx, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
South Bend, IN
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Thornton, CO
Click here to add this to my saved trials
Immunodeficiency Primary Clinical Trial
Study to Investigate Efficacy, Safety and Pharmacokinetics of BT595 in Subjects With PID
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Toledo, OH
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Annadale, VA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Boston, MA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Denver, CO
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Glendale, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Hollywood, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Houston, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Little Rock, AR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Norwich, CT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
San Rafael, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Sommers Point, NJ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
Spokane, WA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
La Mesa, CA
Click here to add this to my saved trials
HIV Clinical Trial
Study of PRO 140 SC as Single Agent Maintenance Therapy in Virally Suppressed Subjects With CCR5-tropic HIV-1 Infection
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
NC Young Women's CoOp
Status: Enrolling
Updated: 12/31/1969
mi
from
High Point, NC
Click here to add this to my saved trials
HIV INfections Clinical Trial
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
La Jolla, CA
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling, Phase IV
Updated: 2/21/2018
mi
from
Fairfax, VA
Click here to add this to my saved trials
Humoral Immune Response Clinical Trial
Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16
Status: Enrolling, Phase IV
Updated: 2/21/2018
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
London,
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
HIV-1 Infection Clinical Trial
B/F/TAF FDC in HIV-1 Infected Virologically Suppressed Adolescents and Children
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Bloemfontein,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Developing a Functional Cure for HIV Disease: Clinical Specimen Collection From HIV Positive Individuals
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
Immunologic Deficiency Syndromes Clinical Trial
Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Status: Enrolling, Phase III
Updated: 11/21/2017
mi
from
Dallas, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
HIV INfections Clinical Trial
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM
Status: Enrolling
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Health and Justice: A Continuum of Care for HIV and SU for Justice-Involved Young Adults (PHASE 2)
Status: Enrolling
Updated: 12/31/1969
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Primary Immunodeficiency Disorders Clinical Trial
The Mechanistic Biology of Primary Immunodeficiency Disorders
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Washington DC,
Click here to add this to my saved trials
HIV INfections Clinical Trial
Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Miami Beach, FL
Click here to add this to my saved trials
HIV Clinical Trial
HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients
Status: Enrolling
Updated: 12/31/1969
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Primary Immunodeficiency Disease Clinical Trial
Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Edmonton,
Click here to add this to my saved trials
1 10 11 12 13 14 15 16 17 18 19 20 21 22